Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vector-Borne Transmission of Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02527005
What this trial is testing

A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ Patients

Who this might be right for
MalariaPregnantHIV
University of Ibadan 140
Testing effectiveness (Phase 2)Study completedNCT03917654
What this trial is testing

Pfs230D1M-EPA/AS01 Vaccine, a Transmission Blocking Vaccine Against Plasmodium Falciparum, in an Age De-Escalation Trial of Children and a Family Compound Trial in Mali

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 1,301
Post-approval studies (Phase 4)Study completedNCT02048007
What this trial is testing

Mortality Reduction After Oral Azithromycin: Morbidity Study

Who this might be right for
Childhood Mortality
University of California, San Francisco 72,000
Early research (Phase 1)Study completedNCT00001136
What this trial is testing

The Effectiveness of an HIV Vaccine (ALVAC vCP205) to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV Vaccine

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableStudy completedNCT04864444
What this trial is testing

Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination Activities

Who this might be right for
Malaria,FalciparumMalaria
University of California, San Francisco 10,715
Early research (Phase 1)Study completedNCT00801697
What this trial is testing

Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 192
Large-scale testing (Phase 3)Study completedNCT02987270
What this trial is testing

Evaluation of Community-based Mass Screening and Treatment for Malaria in Western Kenya

Who this might be right for
Malaria,Falciparum
Simon Kariuki 90,000
Not applicableUnknownNCT04241705
What this trial is testing

Evaluation of Targeted Mass Drug Administration for Malaria in Ethiopia

Who this might be right for
Malaria
Armauer Hansen Research Institute, Ethiopia 48,960
Early research (Phase 1)Study completedNCT01549509
What this trial is testing

Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Testing effectiveness (Phase 2)Study completedNCT00013663
What this trial is testing

Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 92
Large-scale testing (Phase 3)Study completedNCT03576313
What this trial is testing

Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination

Who this might be right for
Malaria
London School of Hygiene and Tropical Medicine 4,939
Early research (Phase 1)Study completedNCT02996695
What this trial is testing

Safety and Efficacy of Sanaria's PfSPZ-CVac in Malian Adults

Who this might be right for
Plasmodium Falciparum Infection
National Institute of Allergy and Infectious Diseases (NIAID) 62
Early research (Phase 1)Study completedNCT01988636
What this trial is testing

Study of Safety and Effectiveness of Intravenous Immunization With PfSPZ Vaccine in Healthy African Adults

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 296
Not applicableStudy completedNCT03534245
What this trial is testing

Investigating Vector-Borne Determinants of Aedes Transmitted Arboviral Infections in Cambodia: An Observational Longitudinal Cohort Study in Children

Who this might be right for
Dengue Fever
National Institute of Allergy and Infectious Diseases (NIAID) 775
Large-scale testing (Phase 3)Study completedNCT03672487
What this trial is testing

Short-course Benznidazole Treatment to Reduce Trypanosoma Cruzi Parasitic Load in Women of Reproductive Age

Who this might be right for
Chagas Disease
Tulane University School of Public Health and Tropical Medicine 87
Not applicableUnknownNCT06182176
What this trial is testing

Effectiveness and Cost-effectiveness of Integrated Model for Malaria and Helminth Control

Who this might be right for
MalariaSoil Transmitted HelminthsSchistosomiasis+2 more
London School of Hygiene and Tropical Medicine 1,200
Testing effectiveness (Phase 2)Study completedNCT02836002
What this trial is testing

Controlled Human Malaria Infection Model for Evaluation of Transmission-Blocking Interventions - Study 1

Who this might be right for
Malaria
Radboud University Medical Center 29
Not applicableStudy completedNCT00126906
What this trial is testing

Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: Malawi

Who this might be right for
Malaria, FalciparumHIV Infections
Centers for Disease Control and Prevention 700
Testing effectiveness (Phase 2)Active Not RecruitingNCT06549257
What this trial is testing

Assessing the Safety, Immunogenicity and Ex-vivo Efficacy of Two Candidate Malaria Transmission Blocking Vaccines, Pfs25-IMX313 and Pfs45/48 Administered Alone and in Combination, in Matrix-M Adjuvant

Who this might be right for
Plasmodium Falciparum Malaria
University of Oxford 56
Early research (Phase 1)Study completedNCT00744133
What this trial is testing

Malaria Challenge With NF54 Strain

Who this might be right for
Plasmodium Falciparum Infection
National Institute of Allergy and Infectious Diseases (NIAID) 37
Next Page